Typical breakthrough cancer pain episodes strike many times a day, peak within minutes and last for about a half hour. Nycomed is developing a new way to help patients gain better control over these episodes and lessen their pain and agony.
In order to promote their intranasal analgesic delivery system designed to closely match typical breakthrough cancer pain episodes, Nycomed collaborated with Sentrix Global Health Communication on a series of ads that illustrate the agony people endure when they suffer from these breakthrough cancer pain attacks.
What's Driving This Trend
- Intranasal Delivery Systems
- Companies can develop new intranasal delivery systems for cancer pain drugs to help patients control their pain more effectively.
- Visual Health Communication
- Healthcare companies should consider using visual health communication techniques to better illustrate patients' pain and suffering to their audience.
- Breakthrough Pain Management
- A new category of pain management solutions can be developed to specifically address the challenges of cancer breakthrough pain episodes.
Who This Affects Most
- Pharmaceutical
- Pharmaceutical companies can focus on developing new drug delivery technologies to address cancer pain sufferers' unmet needs.
- Healthcare Advertising
- New trends in healthcare advertising can use visual imagery to visualize the patient experience and promote patient engagement.
- Pain Management
- A new category of pain management solutions targeted specifically at cancer breakthrough pain episodes can be developed to fill the unmet needs of cancer patients.
